- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Claron releases OEM software
Software developer Claron Technology has formally launched a collection of components designed to help OEMs rapidly develop medical visualization products.
Software developer Claron Technology has formally launched a collection of components designed to help OEMs rapidly develop medical visualization products. These components, dubbed the Withinsight Framework (WIF) platform, speeds the development by OEMs of software that automates segmentation, registration, and the detection of abnormalities; controls the rendering of multiple data volumes; clips and colorizes spatial regions of the data; and measures statistics. WIF supports the development of standalone applications as well as ones that run on thin-client servers. WIF evolved first for internal use by Toronto-based Claron, which a year ago released the platform to seven OEM partners. These OEMs have since applied WIF to develop a range of products CT, MRI, and ultrasound, including ones addressing real-time processing on-board scanners and therapy guidance.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
